Metabolic Vulnerabilities in Brain Cancer

被引：4

作者：

Morrow, Danielle ^{[1
,3
]}

Minami, Jenna ^{[1
,3
]}

Nathanson, David A. ^{[1
,2
,3
]}

机构：

[1] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[3] UCLA CHS 23-234,650 Charles E Young Dr South, Los Angeles, CA 90036 USA

来源：

NEUROSURGERY CLINICS OF NORTH AMERICA | 2021年 / 32卷 / 02期

基金：

美国国家卫生研究院;

关键词：

Metabolism; GBM; Tumor microenvironment; Oncogene; CHOLESTEROL-METABOLISM; CELLULAR-METABOLISM; HUMAN GLIOBLASTOMAS; CO-DEPENDENCY; IDH-MUTANT; CELLS; TUMORS; LANDSCAPE; OXIDATION; GROWTH;

D O I：

10.1016/j.nec.2020.12.006

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Glioblastomas (GBMs) exhibit altered metabolism to support a variety of bioenergetic and biosynthetic demands for tumor growth, invasion, and drug resistance. Changes in glycolytic flux, oxidative phosphorylation, the pentose phosphate pathway, fatty acid biosynthesis and oxidation, and nucleic acid biosynthesis are observed in GBMs to help drive tumorigenesis. Both the genetic landscape of GBMs and the unique brain tumor microenvironment shape metabolism; therefore, an understanding of how both intrinsic and extrinsic factors modulate metabolism is becoming increasingly important for finding effect targets and therapeutics for GBM. © 2021 Elsevier Inc.

引用

页码：159 / 169

页数：11

共 50 条

[41] Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer
Nan Jin
Aiwei Bi
Xiaojing Lan
Jun Xu
Xiaomin Wang
Yingluo Liu
Ting Wang
Shuai Tang
Hanlin Zeng
Ziqi Chen
Minjia Tan
Jing Ai
Hua Xie
Tao Zhang
Dandan Liu
Ruimin Huang
Yue Song
Elaine Lai-Han Leung
Xiaojun Yao
Jian Ding
Meiyu Geng
Shu-Hai Lin
Min Huang
Nature Communications, 10
[42] The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer
Leon-Letelier, Ricardo A.
Dou, Rongzhang
Vykoukal, Jody
Sater, Ali Hussein Abdel
Ostrin, Edwin
Hanash, Samir
Fahrmann, Johannes F.
FRONTIERS IN ONCOLOGY, 2023, 13
[43] TARGETING METABOLIC VULNERABILITIES IN GLIOBLASTOMA
Burban, A.
Sharanek, A.
Bikfalvi, A.
Daubon, T.
NEURO-ONCOLOGY, 2023, 25 : 30 - 30
[44] Metabolic management of brain cancer
Seyfried, Thomas N.
Kiebish, Michael A.
Marsh, Jeremy
Shelton, Laura M.
Huysentruyt, Leanne C.
Mukherjee, Purna
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2011, 1807 (06): : 577 - 594
[45] Metabolic vulnerabilities of dedifferentiated liposarcoma
Brett, Jamie O.
Han, Ji Seul
Kim, Choah
Kelley, Liam P.
Han, SeongJun
Boone, Dylan
Crowley, Joseph
Joshi, Shakchhi
Raut, Chandrajit P.
Greka, Anna
Haigis, Marcia C.
CANCER RESEARCH, 2024, 84 (06)
[46] Metabolic dependencies and vulnerabilities in leukemia
Rashkovan, Marissa
Ferrando, Adolfo
GENES & DEVELOPMENT, 2019, 33 (21-22) : 1460 - 1474
[47] Metabolic Vulnerabilities in Multiple Myeloma
Lim, Julia S. L.
Chong, Phyllis S. Y.
Chng, Wee-Joo
CANCERS, 2022, 14 (08)
[48] Metabolic heterogeneity in breast cancer integrative clusters to screen metabolic vulnerabilities for diagnosis and treatment response.
Ros, Susana
Wright, Alan J.
Bulat, Flaviu
Greenwood, Wendy
Hu, De-en
Callari, Maurizio
Chia, Ming Li
Serra, Violeta
Rueda, Oscar
Bruna, Alejandra
Caldas, Carlos
Brindle, Kevin M.
CANCER RESEARCH, 2021, 81 (13)
[49] Targeting metabolic vulnerabilities to reduce triple negative breast cancer health disparities
Marquez-Garban, Diana C.
Deng, Gang
Burton, Lorena P.
Ma, Gaoyuan
Muhunthan, Vishaka
Comin-Anduix, Begonya
Llarena, Gabriela
Moatamed, Neda
Murphy, Jennifer
Hamilton, Nalo
Shackelford, Daivd
Jung, Michael E.
Pietras, Richard J.
CANCER RESEARCH, 2023, 83 (07)
[50] Identification of cancer vulnerabilities to metabolic perturbation using genome wide CRISPR screens
Chandrashekhar, Megha
Arreger, Michael
Seetharaman, Ashwin
Hart, Traver
Moffat, Jason
CANCER RESEARCH, 2016, 76

← 1 2 3 4 5 →